AOD9604 (Anti-Obesity Drug) is a modified version of the hGH fragment 176-191 peptide (contains a di-sulfide bridge) and thus a derivative of human growth hormone (hGH). Originally developed as a lipolytic (fat burning) compound, AOD9604 has shown benefit in studies of heart disease, osteoarthritis/cartilage repair, and metabolic syndrome. AOD9604 stimulates lipolysis (the breakdown or destruction of fat) and inhibits lipogenesis in animal studies. 

PubChem CID: 16131447
Molecular Formula: C78H125N23O23S2
Molecular Weight: 1817.1 g/mol